Life Sciences BPO Market by Service Type (Water Testing, IVD Testing), by Application (Clinical Testing Methods, Environmental Testing Methods, and Others), by End User (Hospitals & Clinics, Diagnostic Laboratories, Others)- Global Opportunity Analysis and Industry Forecast, 2019 – 2030

Life Sciences BPO Market

Industry:  Life Sciences & Healthcare | Publish Date: Dec 2022 | No of Pages:  N/A | No. Tables:  N/A | No. Figures:  N/A

The Global Life sciences BPO Market size is estimated to be USD 274.25  billion in 2019 and is predicted to reach USD 645.99 billion by 2030 with a CAGR of 8.1% from 2020-2030. Life science business process outsourcing (BPO) is a nascent industry in the healthcare sector. Continuously increasing pricing pressure and elevating competition is pharmaceutical and medical device sector to reduce the operational cost and increase the gross profit margin on the products has increased the demand for the life science BPO services.


Market Dynamics and Trends:

The global life sciences BPO market is majorly driven by rising research and development cost, increasing pricing pressure, and increasing investment by medical devices and pharmaceutical companies in emerging economies. Being a booming sector and continuously increasing demand for the better diagnostic and medical process has led to the rising demand for the outsourcing services. The healthcare industry already possess a huge local and international players, thus many players in the continuously involved in the reducing the operational cost of the products. Pharmaceutical, biotech, and medical device players are outsourcing processes related to product research, manufacturing, and regulatory process services. Outsourcing this helps the companies to focus on their core strengths and increase the productivity and quality of the products which help the company to improve their brand identity.

Continuously increasing number of product launch and increasing prevalence of the various chronic diseases have boosted the market growth. According to the UBM India Pharma Publication, in 2017, over 40 billion USD worth of drug are expected to be off-patent in the U.S. This will surely increase the competition in the market as many players will enter in the race of competition. This factor coupled with the advent of biosimilars is also supported the growth of the global life sciences BPO market during the forecast period 2019-2030.

Demand for outsourcing services in Asia has increased during the last few years owing to large number of FDA approved drug manufacturing plants in this region. As per the report published by the UBM India Pharma Publication in 2015, Over 22% of the total U.S. FDA approved drug manufacturing facilities are present in India. Additionally, dynamics such as huge availability of highly trained professionals, low labor cost, and huge patient pool have boosted the Asia Pacific life sciences BPO market. 

Trade of the drug or medical devices in many countries like America and Europe is regulated by strict laws which is efficiently managed by life science BPO companies. This helps the companies to focus on their core activities such as research, marketing, and sales.

Market Segmentations and Scope of the Study:

The global Life sciences BPO market share is analyzed on the basis of service types, and end user. On the basis of service types the global life sciences BPO is segmented into Water Testing, IVD Testing. On the basis of application the market is divided into Clinical Testing Methods, Environmental Testing Methods, and Others. On the basis of end users the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Others.

Competitive Landscape:

The life sciences BPO market is highly competitive and have the presence of many local and international players vying for the market share. The top companies such as Accenture plc, Anthelio Healthcare Solutions, Quintiles Transnational Corporation, Boehringer Ingelheim GmbH, Infosys Limited,Covance, Inc., ICON plc, Lonza Group, Catalent, Inc., PAREXEL International Corporation, Genpact Ltd., and International Business Machines Corporation dominates the life science BPO market.

 

KEY BENEFITS

  • The study provides an in-depth analysis of the Global life sciences BPO market with current and future trends to elucidate the imminent investment pockets in the market.
  • Current and future life sciences BPO market trends are outlined to determine the overall attractiveness and to single out profitable trends to gain a stronger foothold.
  • The life sciences BPO market report provides information regarding key drivers, restraints and opportunities with impact analysis.
  • Quantitative analysis of the current market and estimations through 2019-2030 are provided to showcase the financial caliber of the life sciences BPO market.
  • Porters Five Forces model and SWOT analysis of the industry illustrates the potency of the buyers & suppliers participating in the life sciences BPO market.
  • Value chain analysis in the life sciences BPO market report provides a clear understanding of the roles of stakeholders involved in the value chain.

KEY MARKET SEGMENTS:

  • Global Life sciences BPO Market – By Service Type
    • Water Testing,
    •  IVD Testing
  • Global Life sciences BPO market – By Application
    • Clinical Testing Methods
    • Environmental Testing Methods
    • Others
  • Global Life sciences BPO market – By End User
    • Healthcare Providers
    • Healthcare Payers
    • Others
  • Global Life sciences BPO market – By Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • Spain
      • UK
      • Italy
      • Russia
      • France
      • Rest of the Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of the Asia Pacific
    • RoW
      • Latin America
      • Middle East
      • Africa

KEY BENEFITS

  • The study provides an in-depth analysis of the Global life sciences BPO market with current and future trends to elucidate the imminent investment pockets in the market.
  • Current and future life sciences BPO market trends are outlined to determine the overall attractiveness and to single out profitable trends to gain a stronger foothold.
  • The life sciences BPO market report provides information regarding key drivers, restraints and opportunities with impact analysis.
  • Quantitative analysis of the current market and estimations through 2019-2030 are provided to showcase the financial caliber of the life sciences BPO market.
  • Porters Five Forces model and SWOT analysis of the industry illustrates the potency of the buyers & suppliers participating in the life sciences BPO market.
  • Value chain analysis in the life sciences BPO market report provides a clear understanding of the roles of stakeholders involved in the value chain.

KEY MARKET SEGMENTS:

  • Global Life sciences BPO Market – By Service Type
    • Water Testing,
    •  IVD Testing
  • Global Life sciences BPO market – By Application
    • Clinical Testing Methods
    • Environmental Testing Methods
    • Others
  • Global Life sciences BPO market – By End User
    • Healthcare Providers
    • Healthcare Payers
    • Others
  • Global Life sciences BPO market – By Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • Spain
      • UK
      • Italy
      • Russia
      • France
      • Rest of the Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of the Asia Pacific
    • RoW
      • Latin America
      • Middle East
      • Africa

KEY PLAYERS

    • Albagaia Ltd.
    • Becton, Dickinson & Company
    • BioMérieux SA
    • Aquacert Ltd.
    • Idexx Laboratories Inc.
    • Merck KGaA
    • Merck Millipore (Merck KGaA)
    • Pall Corporation (Danaher Corporation)
    • Pacific Water Technology
    • Phigenics Llc
    • Qiagen N.V.
    • Thermo Fisher Scientific Inc.
    • Others